Home » Topics » Regulatory » Patents

Patents
RSS

MDR modulators prepared at Janssen

Dec. 4, 1997

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

CoCensys/Acea reveal new AMPA receptor antagonists/positive modulators

Dec. 3, 1997

Antiangina agents in development at Sankyo

Dec. 3, 1997

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

Takeda discloses new series of prolactin secretion inhibitors

Dec. 3, 1997

Maillard reaction inhibitors from Kissei

Dec. 3, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...